Company Data
Stoke Therapeutics Inc.
Ticker
STOK
Current Price
$24.61 5.8%
Market Cap
$1.6B
Price Target
Refer to Report
Volume
691.9K
52wk Range
$20.32 - $40.22
Overview
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels.